WEST PALM BEACH, FLORIDA, UNITED STATES, October 1, 2018 /EINPresswire.com/ -- Ozop Surgical Corp. (OTC: OZSC), a provider of premium surgical devices in the rapidly growing field of minimally invasive surgery (“MIS”), has engaged IR specialists MZ Group (MZ) to manage a comprehensive strategic investor relations and financial communications program across all key markets.

MZ Group will work closely with OZOP Surgical’s management to develop and execute a comprehensive capital markets strategy focused on growing the Company’s visibility in the investment community. The new campaign will highlight OZOP Surgical’s business successes along with its strong leadership in the field of MIS.

Ozop Surgical is a growth oriented minimally invasive orthopedic and neurosurgical implant company with an extensive current offering of high value/high margin surgical products and a robust IP portfolio surrounding MIS. the company’s goal is to change the way spinal fusion is performed.

MZ has a distinguished reputation as a premier resource for institutional investors, brokers, analysts and private investors. The firm has six offices across North America, a strong presence in Asia and Brazil, and maintains extensive relationships with investors throughout Europe. Additionally, MZ Group was recently ranked the No. 1 consultancy in Latin America and No. 7 in the world in business communication.

President of MZ North America, Ted Haberfield, will be advising Ozop Surgical in all facets of corporate and financial communications, including coordinating roadshows in key cities and building brand awareness with the financial media.

“Ozop Surgical is excited to engage MZ Group, the world’s largest independent IR firm, and we look forward to working with MZ to improve our investor relations program,” said Michael Chermak, CEO and Director of Ozop Surgical. “MZ has an exceptional track record, as well as strong connections within the investment community to help us enhance our visibility. We believe our partnership with MZ will lead to an increase in shareholder value for our investor base.”

Matt Hayden, Chairman of MZ Group North America, commented, “MZ Group is pleased to partner with Ozop Surgical, a company that is a pioneer in its field. We believe Ozop Surgical’s story will resonate with our investors, and along with our guidance and experience, will ultimately lead to increased value for the company’s shareholders.”

About Ozop Surgical Corp.
Ozop Surgical, Corp. (www.ozopsurgical.com) invents, designs, develops, manufactures and globally distributes innovative endoscopic instruments, surgical implants, instrumentation, devices and related technologies, focused on spine, neurological and pain management procedures and specialties. Our focus is on economically disrupting the market with clinically equivalent or superior existing and new products resulting in immediate and significant savings for providers, payors and consumers. For more information please visit www.ozopsurgical.com.

About MZ Group
MZ, founded in 1999, combines capital markets intelligence, global investor targeting, IR technology, corporate governance, media and corporate communication and IR consulting, providing comprehensive programs that successfully build and manage shareholder value. With a team of highly experienced senior professionals and an integrated service portfolio, MZ ensures that companies are provided with the right tools and strategies to interact effectively with the investment community and the media, successfully conveying the investment message. MZ's market intelligence, advisory and tactical support activities for investor relations and corporate communications programs are underpinned by a comprehensive IT infrastructure, allowing companies to rapidly achieve global standards of best practices. For more information, please visit www.mzgroup.us.

Contact:

Ted Haberfield
MZ Group - MZ North America
(760) 755-2716
email us here